Browse articles from EyeWorld.org related to MIGS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Two surgeons discussed benefits to expanding access to the suprachoroidal space, which patients might benefit the most, and other important considerations.
Surgeons who routinely perform cataract surgery could better help patients by learning basic glaucoma procedures and incorporating them into cataract surgery, according to two glaucoma surgeons who spoke to EyeWorld. They discussed how cataract surgeons can gain experience with glaucoma procedures and when it makes sense to incorporate them.
➤ Accommodating lens implanted in first patient ➤ First patient dosed in Phase 2 trial investigating treatment for normal tension glaucoma ➤ Primary endpoint met in Phase 3 trial for glaucoma drop ➤ CE mark approvals ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy for Stargardt disease ➤ ASCRS news and events
An emphasis on sustainability in healthcare has gained momentum in recent years. In this article, a group of glaucoma specialists who are experts in sustainability offered their perspectives on how to make meaningful changes in a clinical practice.
➤ ASCRS EyeWorld Weekly: View the current issue ➤ Study: COVID-19 significantly reduced rate of ophthalmic procedures ➤ New device provides non-surgical treatment for lower lid laxity ➤ Autonomous Diabetic Retinopathy Screening offers ‘unparalleled results’ ➤ 52-week data from Phase 2b study evaluating wet AMD therapy ➤ Subgroup analysis provides additional data on wet AMD therapy ➤ ASCRS news and events
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
MIGS has continued to expand in its application for a wide variety of patients with varying degrees of glaucoma. Several physicians discussed where various MIGS procedures fit into interventional glaucoma, including applications for standalone MIGS and how it continues to play a role in conjunction with cataract surgery.
Many MIGS procedures are proving useful and accessible not just to the glaucoma specialist but to comprehensive ophthalmologists as well. Two ophthalmologists discussed who should be performing glaucoma surgery, as well as ways to learn and stay fresh with some of these techniques.
Two surgeons shared their insights on the pearls they have gained using the XEN Gel Stent (AbbVie), which originally received FDA approval in 2016.